New treatment enters Rx sleep aid market
A new insomnia treatment entered the increasingly competitive insomnia market Friday as the FDA approved Takeda Pharmaceuticals’ Rozerem.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.